MedTech regulatory readiness through an investor lens – bridging the gap to decisive competitive advantage

Join Tay Health Tech and InnoScot Health this autumn for a medical device regulation workshop which invites MedTech innovators to learn how to marry product compliance with commercial success, helping to accelerate market entry, build trust, and drive stronger revenue.

The deep dive in-person event – entitled ‘MedTech regulatory readiness through an investor lens – bridging the gap to decisive competitive advantage’ – is set to bring together medical device innovators, regulatory experts, and the investment community to offer cutting-edge knowledge and valuable insights at the COSLA Conference Centre in Edinburgh on Wednesday 4 November.

Organisers say it will provide the practical knowledge and support required to bridge a significant gap in understanding which is routinely encountered – making the leap from securing regulatory approval to gaining investor confidence. They believe that it is vital to see issues from the point of view of the investment community, with the workshop offering first hand experience of how MedTech investors assess regulatory preparedness during screening, valuation, and due diligence.

Following on from the success of a similar event held in Dundee in June, the day is expected to attract a wide-ranging MedTech sector audience from across Scotland and beyond, including:

• Pre-startup companies and academics who are new to medical device regulations
• MedTech startups or spinouts at an early stage of development
• SMEs preparing for external investment.

The workshop has been organised by the Tay Health Tech initiative, funded with the Engineering & Physical Research Council (EPSRC), in collaboration with leading healthcare innovation body InnoScot Health.

Sessions will be taking place across the day, including a ‘Refresher on Regulatory Landscape for Medical Devices and Implications on Business Plan’ presented by Elaine Gemmell, Head of Regulatory Affairs at InnoScot Health.

Furthermore, attendees will benefit from the vast knowledge of Vicki Hazley, Associate Director of the Scottish National Investment Bank which regularly invests in life sciences. Vicki is an expert in investment portfolio management.

Director of Portfolio at Eos Advisory LLP, Anne Muir – formerly deputy director for research and innovation services at the University of Dundee – will be sharing candid advice based around the investment firm’s commitment to backing science-based companies and founders developing technologies that can positively impact lives.

Edward Staunton, Director, Regulatory Affairs & Quality, Medical Devices at Clinigen, has also been confirmed to be presenting a session on regulatory strategy and key considerations with the ultimate aim of giving attendees a clear view of what regulatory preparedness looks like.

With more expert speakers set to be confirmed, the day – lasting from 10am-4pm – will encompass real-world case studies, networking opportunities, as well as coffee and lunch breaks.

Interested parties are urged to register now and ensure their place.